Tumor Organoids

We are dedicated to advancing cancer research through cutting-edge techniques and innovative approaches. Our focus lies in studying both intratumoral and spatial heterogeneity to develop personalized medicine strategies that improve cancer treatment outcomes.

At our lab, we harness the power of cancer organoids and assembloids to dissect the complexity of tumors. These three-dimensional models faithfully recapitulate the cellular heterogeneity and spatial organization found in patient tumors, allowing us to study how spatial arrangements of different cell populations influence tumor behavior and response to therapy.

By utilizing these models, we aim to unravel the intricate interactions between different cell populations within tumors, shedding light on the underlying mechanisms driving tumor progression and therapeutic response. Through our research efforts, we seek to translate these findings into clinical applications that benefit cancer patients.

By testing therapeutic interventions on patient-derived organoids and assembloids, we strive to identify personalized treatment strategies tailored to individual patients, accounting for both intratumoral and spatial heterogeneity. Our ultimate goal is to contribute to the development of more effective and targeted cancer therapies, ultimately improving patient outcomes.